Keyphrases
Antiphospholipid Syndrome
100%
Antiphospholipid Antibodies
49%
Recurrent Miscarriage
41%
Preeclampsia
38%
During Pregnancy
24%
Dermal Fillers
23%
Pregnant Women
22%
Hydroxychloroquine
22%
Thrombosis
20%
Autoimmune Disease
20%
Late-onset
18%
Immune-related Adverse Effects
17%
Pregnancy Outcome
16%
Lupus Anticoagulant
16%
Obstetric Complications
16%
Biomaterials
15%
European Registries
15%
Silicone
14%
Obstetric Outcomes
14%
Maternal Outcomes
14%
Autoimmune
14%
Angiogenic Factors
13%
Inflammatory Syndrome
13%
Adverse Reactions
13%
Miscarriage
13%
Fetal Loss
12%
Placental Growth Factor (PlGF)
12%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
12%
Adverse Effects
11%
Cell-derived Microparticles
11%
Live Birth
10%
Immune-mediated Adverse Reactions
10%
Multicenter Retrospective Study
10%
Systemic Lupus Erythematosus
10%
Low Molecular Weight Heparin
10%
Sydney
9%
Inflammatory Cytokines
9%
Antiphospholipid
9%
Regulatory T Cells
9%
Inflammatory Immune Response
9%
Fetus
9%
Hyaluronic Acid
9%
Low-dose Aspirin
9%
β2-glycoprotein I (β2GPI)
9%
Selective Intrauterine Growth Restriction (sIUGR)
9%
Anticardiolipin
8%
Tumor Necrosis Factor-α
8%
Inherited Thrombophilia
8%
COVID-19
8%
Non-criteria
8%
Medicine and Dentistry
Antiphospholipid Syndrome
80%
Obstetrics
54%
Adverse Event
37%
Immunity
37%
Antiphospholipid Antibody
36%
Recurrent Miscarriage
34%
Pre-Eclampsia
32%
Autoimmune Disease
20%
Diseases
20%
Hydroxychloroquine
18%
Systemic Lupus Erythematosus
15%
Retrospective Study
15%
Membrane Microparticle
14%
Prevalence
14%
Systematic Review
14%
Clinical Finding
13%
Spontaneous Abortion
12%
Fetus Wastage
12%
Thrombosis
12%
Biocompatible Material
11%
Implant
11%
Lupus Anticoagulant
10%
Low Drug Dose
10%
Pregnancy
9%
Serositis
9%
Obstetric Complication
9%
Cytokine
9%
Acetylsalicylic Acid
9%
Fetus Growth
9%
Angiogenic Factor
8%
Restylane
8%
Antiangiogenic
8%
Intrauterine Growth Retardation
8%
Adjuvant
7%
Thrombophilia
7%
Tumor Necrosis Factor
7%
Fetus Death
7%
Uterine Artery
7%
Therapeutic Management
7%
Granulomatosis
6%
Lupus Erythematosus Panniculitis
6%
Autoimmune Rheumatic Disease
6%
Cyclosporine
6%
Parthenogenesis
6%
Immunomodulation
6%
Placental Growth Factor
6%
Birth Rate
6%
Bleeding
6%
Low Molecular Weight Heparin
6%
Meta-Analysis
6%